Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Carlos J Maldonado, Evan Ewers et al.|Clinical Infectious Diseases|2022Cited by 59
Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Daniel E. Clark, Eric D. Laing et al.|The Journal of Infectious Diseases|2021Cited by 42
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to HealthStephanie A Richard, Josh Chenoweth, Nusrat J Epsi et al.|Open Forum Infectious Diseases|2022Cited by 14
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionI Scher, LTC D Hostler, Catherine M Berjohn et al.|Open Forum Infectious Diseases|2022Cited by 8
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort StudyStephanie A Richard, N Dimascio-Johnson, I Scher et al.|Open Forum Infectious Diseases|2023Cited by 6